Molecular Biomarkers of Response to Radiation Therapy in Breast Cancer
Recruiting
Observational Study
Breast Cancer
Radiotherapy Side Effect
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 75
- Sex
- Female
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- Institute of Oncology Ljubljana · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to identify potential genetic and other molecular biomarkers of response to radiation therapy in breast cancer that may help to personalize breast cancer radiation treatment in the future.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Breast cancer patients with DCIS with an indication for adjuvant radiation therapy
Exclusion Criteria:
* Any specific systemic oncological therapy
Contacts